37 related articles for article (PubMed ID: 3079898)
1. Comparative study on three chemotherapeutic regimens for the treatment of advanced epithelial ovarian cancer.
Wang C; Gu M; Wang S; Ma D
J Tongji Med Univ; 2000; 20(4):343-4. PubMed ID: 12840932
[TBL] [Abstract][Full Text] [Related]
2. Response to D-Trp-6-luteinising hormone releasing hormone (Decapeptyl) microcapsules in advanced ovarian cancer.
Parmar H; Rustin G; Lightman SL; Phillips RH; Hanham IW; Schally AV
Br Med J (Clin Res Ed); 1988 Apr; 296(6631):1229. PubMed ID: 2968130
[No Abstract] [Full Text] [Related]
3. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.
Louie KG; Ozols RF; Myers CE; Ostchega Y; Jenkins J; Howser D; Young RC
J Clin Oncol; 1986 Nov; 4(11):1579-85. PubMed ID: 3095501
[TBL] [Abstract][Full Text] [Related]
5. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
6. Recurrent ovarian carcinoma: retreatment utilizing combination chemotherapy including cis-diamminedichloroplatinum in patients previously responding to this agent.
Seltzer V; Vogl S; Kaplan B
Gynecol Oncol; 1985 Jun; 21(2):167-76. PubMed ID: 3921437
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-MECY (methotrexate-leucovorin rescue plus cyclophosphamide) versus cisplatin-CHAD (cyclophosphamide, hexamethylmelamine, doxorubicin, and cisplatin) as initial chemotherapy in stage III-IV ovarian adenocarcinoma.
Barlow JJ; Lele SB
Cancer Treat Rep; 1984 Dec; 68(12):1433-8. PubMed ID: 6439408
[TBL] [Abstract][Full Text] [Related]
8. Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma.
Richman CM; Podczaski E; Weiser PA; Herbst AL
Oncology; 1986; 43(1):12-7. PubMed ID: 3079898
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapeutic management of ovarian cancer.
Dembo AJ
Semin Oncol; 1984 Sep; 11(3):238-50. PubMed ID: 6435249
[No Abstract] [Full Text] [Related]
11. [Chemotherapy of advanced epithelial ovarian carcinoma].
Meerpohl HG
Onkologie; 1984 May; 7 Suppl 2():22-34. PubMed ID: 6431349
[TBL] [Abstract][Full Text] [Related]
12. The role of hexamethylmelamine in the management of ovarian cancer.
Schein PS; Scheffler B; McCulloch W
Cancer Treat Rev; 1991 Mar; 18 Suppl A():67-75. PubMed ID: 1904311
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
